MORAb-003, a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer |
| |
| Authors: | Kalli Kimberly R |
| |
| Affiliation: | Mayo Clinic College of Medicine, Women's Cancer Program, 200 First Street SW, Rochester, MN 55905, USA. kalli.kimberly@mayo.edu |
| |
| Abstract: | Morphotek Inc is developing MORAb-003, a humanized monoclonal antibody directed against folate receptor alpha, for the potential treatment of ovarian cancer. Phase II clinical trialsof MORAb-003, either alone or in combination with platinum/taxane chemotherapy, are underway in ovarian cancer patients experiencing their first disease recurrence. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
